Literature DB >> 26902495

Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis.

Gil F Salles1, Gianpaolo Reboldi2, Robert H Fagard2, Claudia R L Cardoso2, Sante D Pierdomenico2, Paolo Verdecchia2, Kazuo Eguchi2, Kazuomi Kario2, Satoshi Hoshide2, Jorge Polonia2, Alejandro de la Sierra2, Ramon C Hermida2, Eamon Dolan2, Eoin O'Brien2, George C Roush2.   

Abstract

The prognostic importance of the nocturnal systolic blood pressure (SBP) fall, adjusted for average 24-hour SBP levels, is unclear. The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) examined this issue in a meta-analysis of 17 312 hypertensives from 3 continents. Risks were computed for the systolic night-to-day ratio and for different dipping patterns (extreme, reduced, and reverse dippers) relative to normal dippers. ABC-H investigators provided multivariate adjusted hazard ratios (HRs), with and without adjustment for 24-hour SBP, for total cardiovascular events (CVEs), coronary events, strokes, cardiovascular mortality, and total mortality. Average 24-hour SBP varied from 131 to 140 mm Hg and systolic night-to-day ratio from 0.88 to 0.93. There were 1769 total CVEs, 916 coronary events, 698 strokes, 450 cardiovascular deaths, and 903 total deaths. After adjustment for 24-hour SBP, the systolic night-to-day ratio predicted all outcomes: from a 1-SD increase, summary HRs were 1.12 to 1.23. Reverse dipping also predicted all end points: HRs were 1.57 to 1.89. Reduced dippers, relative to normal dippers, had a significant 27% higher risk for total CVEs. Risks for extreme dippers were significantly influenced by antihypertensive treatment (P<0.001): untreated patients had increased risk of total CVEs (HR, 1.92), whereas treated patients had borderline lower risk (HR, 0.72) than normal dippers. For CVEs, heterogeneity was low for systolic night-to-day ratio and reverse/reduced dipping and moderate for extreme dippers. Quality of included studies was moderate to high, and publication bias was undetectable. In conclusion, in this largest meta-analysis of hypertensive patients, the nocturnal BP fall provided substantial prognostic information, independent of 24-hour SBP levels.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; blood pressure monitoring, ambulatory; hypertension; meta-analysis; publication bias

Mesh:

Substances:

Year:  2016        PMID: 26902495     DOI: 10.1161/HYPERTENSIONAHA.115.06981

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  112 in total

Review 1.  [Antihypertensive therapy in the elderly].

Authors:  J Schrader; B Schrader
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

2.  Nocturnal Blood Pressure Dipping is Abolished in Old-Elderly Hospitalized Patients.

Authors:  Francesco Salvo; Chiara Lonati; Michele Berardi; Andrea Riccardo Errani; Carlo Lorenzo Muzzulini; Alberto Morganti
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-22

Review 3.  Disturbed Sleep as a Mechanism of Race Differences in Nocturnal Blood Pressure Non-Dipping.

Authors:  Marissa A Bowman; Daniel J Buysse; Jillian E Foust; Vivianne Oyefusi; Martica H Hall
Journal:  Curr Hypertens Rep       Date:  2019-05-22       Impact factor: 5.369

Review 4.  Effects of calcium plus vitamin D supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials.

Authors:  L Wu; D Sun
Journal:  J Hum Hypertens       Date:  2017-02-23       Impact factor: 3.012

Review 5.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

6.  Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.

Authors:  Teresa Gijón-Conde; Auxiliadora Graciani; Esther López-García; Pilar Guallar-Castillón; Esther García-Esquinas; Fernando Rodríguez-Artalejo; José R Banegas
Journal:  Hypertens Res       Date:  2017-02-09       Impact factor: 3.872

Review 7.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

Review 8.  Masked Hypertension: Whom and How to Screen?

Authors:  D Edmund Anstey; Nathalie Moise; Ian Kronish; Marwah Abdalla
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

9.  Night-time systolic blood pressure and subclinical cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study.

Authors:  Koki Nakanishi; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Joseph E Schwartz; Tetz C Lee; Aylin Tugcu; Mitsuhiro Yoshita; Charles DeCarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-07-01       Impact factor: 6.875

10.  Circadian hemodynamics in men and women with high blood pressure: dipper vs. nondipper and racial differences.

Authors:  Andrew Sherwood; LaBarron K Hill; James A Blumenthal; Alan L Hinderliter
Journal:  J Hypertens       Date:  2018-02       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.